918博天娱乐·(中国)官方网站
Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(华堂宁®)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
中
繁
中
繁
中
Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(华堂宁®)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
Investor Relations
>
Investor Relations
>
Announcements and Circulars
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Announcements and Circulars
Search
Jun 24, 2019
Change of address of hong kong branch share registrar and transfer office
Read More
Jun 14, 2019
Revised form of proxy for the annual general meeting to be held on monday, june 24, 2019
Read More
Jun 14, 2019
Clarification announcement on notice of annual general meeting, circular and proxy form
Read More
Jun 07, 2019
Monthly Return
Read More
Jun 05, 2019
Voluntary Announcement - Business & Pipeline Update
Read More
May 17, 2019
Notice of Annual General Meeting
Read More
May 17, 2019
General Mandates to Buyback and Issue Shares, Re-election of Directors, Approval of Share Option Grant...
Read More
May 17, 2019
Form of Proxy
Read More
May 07, 2019
Monthly Return
Read More
Apr 29, 2019
Hua Medicine Annual Report
Read More
Apr 23, 2019
Voluntary Announcement First Combination Study Of Drzag With A SGLT-2 Inhibitor In The United States
Read More
Apr 03, 2019
Monthly Return
Read More
<<
<
9
10
11
12
13
14
15
16
17
18
19
>
>>
上一页
下一页
About Us
Company Overview
Company History
Leadership Team
Portfolio Advisory Board
Senior Scientific Advisory Board
Partner
Media center
Research & Development
Inovation
Pipeline
Dorzagliatin
mGluR5
Company Publications
Peer Reviewed Publications
Investor Relations
Corporate Governance
Financial Report
Announcements & Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock information
Media
Company News
Media Releases
Video
Careers
Culture
Join Us
Product
HuaTangNing(华堂宁®)
Subscribe Email
Focus Us
Copyright © 2024 Hua Medicine (Shanghai) Co., Ltd. 互联网药品信息服务资格证书编号: （沪）-非经营-2022-0079
沪ICP备14036654号-1
沪公网安备 31011502013809号
Privacy Statement
Terms of Use
Search
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our
privacy statement
.
Accept
x
友情链接:
尊龙凯时 - 人生就是搏!
尊龙凯时·(中国区)人生就是搏!
尊龙凯时人生就是搏z6com
尊龙凯时
尊龙人生就是博中国区
沪公网安备 31011502013809号 Privacy Statement Terms of Use
